Published in Nat Med on April 01, 2000
VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest (2000) 4.36
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A (2009) 2.29
Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J Clin Invest (2003) 1.85
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest (2003) 1.84
Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest (2001) 1.73
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther (2005) 1.63
Roles for VEGF in the adult. Microvasc Res (2007) 1.48
Cardiovascular actions of neurotrophins. Physiol Rev (2009) 1.45
VEGF: a critical player in neurodegeneration. J Clin Invest (2004) 1.29
Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword. Adv Exp Med Biol (2004) 1.17
VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. Am J Pathol (2013) 1.14
VEGF in the nervous system. Organogenesis (2010) 1.13
Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation (2009) 1.10
Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J Clin Invest (2008) 1.08
Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1. Gene (2005) 1.07
Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization. Proc Natl Acad Sci U S A (2002) 1.03
Blood flow per unit retinal nerve fibre tissue volume is lower in the human inferior retina. Br J Ophthalmol (2003) 1.00
Paracrine control of vascularization and neurogenesis by neurotrophins. Br J Pharmacol (2003) 0.96
Intracellular pathways triggered by the selective FLT-1-agonist placental growth factor in vascular smooth muscle cells exposed to hypoxia. Br J Pharmacol (2005) 0.94
A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice. Cardiovasc Res (2009) 0.93
Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons. FASEB J (2011) 0.92
Can VEGF reverse diabetic neuropathy in human subjects? J Clin Invest (2001) 0.92
Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression. Gene Ther (2009) 0.86
Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic mice. Neurobiol Dis (2012) 0.86
Fast rearrangement of the neuronal growth cone's actin cytoskeleton following VEGF stimulation. Histochem Cell Biol (2012) 0.85
VEGFA family isoforms regulate spermatogonial stem cell homeostasis in vivo. Endocrinology (2011) 0.84
Keeping in touch with angiogenesis. Nat Med (2000) 0.83
Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling. Mol Ther (2014) 0.82
Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy. Ther Adv Endocrinol Metab (2010) 0.82
Omentum-wrapped scaffold with longitudinally oriented micro-channels promotes axonal regeneration and motor functional recovery in rats. PLoS One (2011) 0.81
Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves. Endocr Metab Immune Disord Drug Targets (2012) 0.79
Identifying Common Genetic Risk Factors of Diabetic Neuropathies. Front Endocrinol (Lausanne) (2015) 0.79
Cell therapy for diabetic neuropathy using adult stem or progenitor cells. Diabetes Metab J (2013) 0.77
Intense Exercise Promotes Adult Hippocampal Neurogenesis But Not Spatial Discrimination. Front Cell Neurosci (2017) 0.75
Gene therapy for the treatment of diabetic neuropathy. Curr Diab Rep (2008) 0.75
Clinical improvement after treatment with VEGF(165) in patients with severe chronic lower limb ischaemia. Genomic Med (2007) 0.75
Immune dysregulation in patients with carpal tunnel syndrome. Sci Rep (2017) 0.75
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest (1984) 5.19
Mouse model of angiogenesis. Am J Pathol (1998) 4.28
Ore leaching by bacteria. Annu Rev Microbiol (1980) 4.28
Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation (2001) 4.17
The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest (1993) 4.11
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 4.10
The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med (2001) 3.85
Mortality of sea lions along the central California coast linked to a toxic diatom bloom. Nature (2000) 3.82
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79
Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation (1999) 3.62
Age-dependent impairment of angiogenesis. Circulation (1999) 3.47
Apoptosis in human atherosclerosis and restenosis. Circulation (1995) 3.30
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest (1994) 3.11
Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology (2002) 2.98
The large, oxygen-rich halos of star-forming galaxies are a major reservoir of galactic metals. Science (2011) 2.95
Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation (1999) 2.92
Identification of cellular proteins required for simian virus 40 DNA replication. J Biol Chem (1989) 2.84
A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2. Proc Natl Acad Sci U S A (1983) 2.83
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol (1999) 2.83
Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation (1996) 2.79
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med (1997) 2.73
Birth of a biome: insights into the assembly and maintenance of the Australian arid zone biota. Mol Ecol (2008) 2.73
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression. J Virol (1986) 2.54
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis (2010) 2.51
Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol (1999) 2.48
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer (2009) 2.39
Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med (1986) 2.32
Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature (1967) 2.29
Thiobacillus acidophilus sp. nov.; isolation and some physiological characteristics. Can J Microbiol (1975) 2.28
Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation (1998) 2.25
Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation (1992) 2.20
Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem (1995) 2.20
HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest (2001) 2.20
Pain in Guillain-Barré syndrome. Arch Neurol (1984) 2.19
Acute cardiac events temporally related to cocaine abuse. N Engl J Med (1986) 2.18
Congenital anomalies in American Indians of British Columbia. Genet Epidemiol (1986) 2.13
Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem (1998) 2.12
Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation (2000) 2.12
Limb body wall complex: I. Pathogenesis. Am J Med Genet (1987) 2.11
Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science (1985) 2.09
Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation (1994) 2.08
Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation (1995) 2.07
Duration of untreated psychosis and 12-month outcome in first-episode psychosis: the impact of treatment approach. Acta Psychiatr Scand (1999) 2.06
Nonvasculitic, steroid-responsive mononeuritis multiplex. Neurology (1993) 2.05
Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation (2000) 2.05
Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res (2000) 2.04
Our national obsession with potassium. Am J Med (1982) 2.02
A prospective study of preferred versus actual place of death among patients referred to a palliative care home-care service. Ir Med J (2002) 2.00
Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol (1997) 1.98
Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol (1986) 1.97
Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med (1979) 1.96
Prenatally diagnosed neural tube defects: ultrasound, chromosome, and autopsy or postnatal findings in 212 cases. Am J Med Genet (1998) 1.94
Centenarians: the older you get, the healthier you have been. Lancet (1999) 1.92
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92
Human immune globulin infusion in Guillain-Barré syndrome: worsening during and after treatment. Neurology (1993) 1.90
Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation (1995) 1.90
A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol (2004) 1.87
The initial product and properties of the sulfur-oxidizing enzyme of thiobacilli. Biochim Biophys Acta (1966) 1.85
Remote frozen section service: a telepathology project in northern Norway. Hum Pathol (1991) 1.83